Skip to main content
. 2021 Oct 14;3:725844. doi: 10.3389/fmedt.2021.725844

Figure 4.

Figure 4

AAV compatibility tests. (A) AAV concentration before and after CED through MINT at 3, 5, and 10 μL/min. D1, D2, and D3 denote 1:1000, 1:5000, and 1:25000 AAV dilutions, respectively (*p < 0.05 compared to initial titer by Sidak post-hoc multiple comparisons analysis). (B) Change in AAV concentration after CED through MINT. Each point represents the average of n = 3 repeats in each trial. Horizontal line shows mean, error bar is the standard deviation.